EOLS - Evolus, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Newport Beach,
United States
Type: Equity
EOLS price evolution
EOLS
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $62.84 | $38.69 | $41.7 | $31.46 |
| Short term investments | ||||
| Net receivables | $30.53 | $30.46 | $29 | $23.45 |
| Inventory | $11 | $17.63 | $19.86 | $23.42 |
| Total current assets | $112.42 | $92 | $96.46 | $84.08 |
| Long term investments | ||||
| Property, plant & equipment | $7.85 | $8.04 | $3.88 | $4.33 |
| Goodwill & intangible assets | $68.32 | $67.71 | $68.42 | $69.14 |
| Total noncurrent assets | $76.58 | $75.97 | $72.52 | $76.15 |
| Total investments | ||||
| Total assets | $189 | $167.97 | $168.98 | $160.24 |
| Current liabilities | ||||
| Accounts payable | $4.27 | $11.76 | $7.83 | $10.19 |
| Deferred revenue | ||||
| Short long term debt | $1.38 | $1.36 | $1.35 | $1.33 |
| Total current liabilities | $48.29 | $48.54 | $41.35 | $40.68 |
| Long term debt | $125.17 | $100.08 | $95.47 | $72.99 |
| Total noncurrent liabilities | $161.4 | $138.8 | $134.6 | $112.61 |
| Total debt | $126.55 | $101.44 | $96.82 | $74.32 |
| Total liabilities | $209.69 | $187.34 | $175.95 | $153.29 |
| Shareholders' equity | ||||
| Retained earnings | -$558.98 | -$547.15 | -$530.23 | -$512.09 |
| Other shareholder equity | -$0.43 | -$0.61 | -$0.47 | -$0.42 |
| Total shareholder equity | -$20.69 | -$19.37 | -$6.96 | $6.95 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $62.84 | $53.92 | $146.26 | $102.56 |
| Short term investments | $5 | |||
| Net receivables | $30.53 | $22.45 | $14.66 | $9.68 |
| Inventory | $11 | $18.85 | $1.76 | $3.35 |
| Total current assets | $112.42 | $100.8 | $178.8 | $127.61 |
| Long term investments | ||||
| Property, plant & equipment | $7.85 | $4.56 | $4.09 | $4.71 |
| Goodwill & intangible assets | $68.32 | $69.81 | $71.83 | $76.5 |
| Total noncurrent assets | $76.58 | $77.18 | $78.68 | $81.46 |
| Total investments | $5 | |||
| Total assets | $189 | $177.98 | $257.48 | $209.07 |
| Current liabilities | ||||
| Accounts payable | $4.27 | $8.94 | $6.09 | $9.62 |
| Deferred revenue | ||||
| Short long term debt | $1.38 | $1.32 | $1.26 | $94.66 |
| Total current liabilities | $48.29 | $46.51 | $57.66 | $180.25 |
| Long term debt | $125.17 | $71.88 | $73.48 | $43.65 |
| Total noncurrent liabilities | $161.4 | $112.97 | $117.94 | $101.78 |
| Total debt | $126.55 | $74.42 | $74.74 | $138.32 |
| Total liabilities | $209.69 | $159.48 | $175.61 | $282.03 |
| Shareholders' equity | ||||
| Retained earnings | -$558.98 | -$497.29 | -$422.88 | -$376.07 |
| Other shareholder equity | -$0.43 | -$0.34 | ||
| Total shareholder equity | -$20.69 | $18.5 | $81.88 | -$72.96 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $61 | $49.35 | $41.72 | |
| Cost of revenue | $19.27 | $14.71 | $12.15 | |
| Gross Profit | $41.73 | $34.63 | $29.57 | |
| Operating activities | ||||
| Research & development | $2.38 | $1.21 | $1.38 | |
| Selling, general & administrative | $43.06 | $41.17 | $37.38 | |
| Total operating expenses | $50.36 | $49.75 | $41.62 | |
| Operating income | -$8.63 | -$15.12 | -$12.04 | |
| Income from continuing operations | ||||
| EBIT | -$7.65 | -$14.94 | -$11.98 | |
| Income tax expense | $0.11 | $0.02 | $0.02 | |
| Interest expense | $4.08 | $3.18 | $2.79 | |
| Net income | ||||
| Net income | -$11.83 | -$18.14 | -$14.79 | |
| Income (for common shares) | -$11.83 | -$18.14 | -$14.79 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $202.09 | $148.62 | $99.67 | $56.54 |
| Cost of revenue | $61.56 | $55.89 | $43.53 | $18.3 |
| Gross Profit | $140.53 | $92.73 | $56.14 | $38.24 |
| Operating activities | ||||
| Research & development | $6.56 | $4.74 | $2.06 | $1.72 |
| Selling, general & administrative | $164.94 | $141.84 | $112.07 | $98.19 |
| Total operating expenses | $189.76 | $158.06 | $100.54 | $191.31 |
| Operating income | -$49.23 | -$65.33 | -$44.41 | -$153.07 |
| Income from continuing operations | ||||
| EBIT | -$47.68 | -$65.22 | -$45.37 | -$152.43 |
| Income tax expense | $0.18 | $0.1 | $0.04 | $0.08 |
| Interest expense | $13.83 | $9.1 | $1.4 | $10.5 |
| Net income | ||||
| Net income | -$61.69 | -$74.41 | -$46.81 | -$163.01 |
| Income (for common shares) | -$61.69 | -$74.41 | -$46.81 | -$163.01 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$11.83 | -$16.92 | -$18.14 | -$14.79 |
| Operating activities | ||||
| Depreciation | $1.52 | $1.48 | $1.46 | $1.41 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.4 | $4.6 | $4.17 | $3.29 |
| Total cash flows from operations | $0.81 | -$0.92 | -$13.31 | -$20.59 |
| Investing activities | ||||
| Capital expenditures | -$0.36 | -$0.54 | -$0.22 | -$0.51 |
| Investments | ||||
| Total cash flows from investing | -$0.36 | -$0.54 | -$0.22 | -$0.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.03 | $0.06 | $0.11 | $0.03 |
| Net borrowings | $24.99 | $24.96 | ||
| Total cash flows from financing | $23.52 | -$1.42 | $23.82 | -$1.28 |
| Effect of exchange rate | $0.18 | -$0.14 | -$0.05 | -$0.08 |
| Change in cash and equivalents | $24.15 | -$3.02 | $10.24 | -$22.46 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$61.69 | -$74.41 | -$46.81 | -$163.01 |
| Operating activities | ||||
| Depreciation | $5.87 | $4.5 | $6.31 | $7.68 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $16.46 | $10.83 | $9.58 | $10.58 |
| Total cash flows from operations | -$34.01 | -$84.91 | -$33.39 | -$57.87 |
| Investing activities | ||||
| Capital expenditures | -$1.63 | -$2.94 | -$0.97 | -$3.14 |
| Investments | $5 | $15.33 | ||
| Total cash flows from investing | -$1.63 | -$2.94 | $4.03 | $12.19 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.22 | $0.54 | $103.99 | |
| Net borrowings | $49.95 | -$0.5 | -$27.63 | $39.48 |
| Total cash flows from financing | $44.64 | -$4.15 | $73.05 | $38.35 |
| Effect of exchange rate | -$0.09 | -$0.34 | ||
| Change in cash and equivalents | $8.92 | -$92.33 | $43.69 | -$7.33 |
News
Fundamentals
| Market cap | $662.62M |
|---|---|
| Enterprise value | $726.33M |
| Shares outstanding | 57.82M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 39.76% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | -32.70 |
| Book/Share | -0.35 |
| Cash/Share | 1.09 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -10.14 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.33 |
| Quick ratio | 2.10 |